Company ProfilePremium

Metabolon, Inc.

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Metabolon, Inc. - Healthcare showcase

Year Founded & Workforce

2000

200 Employees

Industry

Healthcare

Services

Technology MetabolomicsClinical & Consumer Applications
M

Metabolon, Inc. Employee Contacts

45 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Metabolon, Inc. Overview

Company Headquarters: Morrisville, US

Founded: 2000

Workforce: ~200

Company Working: Metabolon, Inc. is a leading diagnostic service provider company which offers customized and scalable metabolomics solutions used in research and product development by biopharma, academic research sectors, and biotech companies. Under its metabolomics platform, the company provides different products which are used in biological understandings of disease state and biological reactions in the present time. The company specializes in biomarkers, metabolomics, diagnostic tests, and clinical study design.

Strategy

Metabolon, Inc. primarily focuses on mergers, acquisitions, partnerships, and collaboration with research organizations and companies having strong R&D capabilities and advanced technology. The company uses its technology across different research areas including cancer, cardiovascular disease, neurology, genomics, metabolic and immunology, and more to offer new product and services.

Company Snapshot

200

Employees

2000

Founded

Morrisville, US

Headquarters

SWOT Analysis

Strengths

  • Leading health technology company
  • Strong research & development team

Weaknesses

  • Limited products
  • Primary focus on the US market

Opportunities

  • Launching more innovative products
  • Expanding presence in emerging countries

Threats

  • Price capping in medical device industry
  • Presence of alternative products

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
July 2019PartnershipMetabolon, Inc. joined with three research groups based in Canada—the Canadian Longitudinal Study of Aging (CLSA), the Canadian Frailty Network, and the McMaster Institute for Research on Aging (MIRA). Through this partnership, the organizations are in the process to develop a USD 4 million research program to achieve large-scale metabolomic profiling and biomarker identification.
March 2018ExpansionMetabolon, Inc. opened a metabolomics laboratory in collaboration with Zhejiang Dian Diagnostics Co., Ltd ("DIAN") in China. The opening of this laboratory in China enabled the company to increase its global footprint.
September 2017AcquisitionMetabolon, Inc. acquired Metabolomic Discoveries GmbH, a Germany-based company. The acquisition of Metabolomic Discoveries GmbH provided a strength to develop a strong product portfolio for metabolomics in various regions around the globe.

Product Offering

  • Metabolon, Inc.
    • Technology Metabolomics
    • Clinical & Consumer Applications

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.